市中肺炎に続発する中~重症ARDSにおいて、ΔP制限戦略(PEEPを最良の静的呼吸器系コンプライアンスで設定+ΔP≦14)は標準的な低PEEP戦略(ARDSnetの低PEEP表)と比べ、28日以内の非レスピ日数を増加させなかった、というRCT。 ΔPうんぬんよりPEEPはnetの表で悪くないのなってゆう https://t.co/wTYtLNdusb
Effect of a driving pressure-limiting strategy for patients with acute respiratory distress syndrome secondary to community-acquired pneumonia: the STAMINA randomised clinical trial.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Nov 2024 – May 2025Where it's discussed
-
X / Twitter12 posts
-
YouTube2 videos
-
Blogs2 articles
-
Bluesky1 posts
AI synopsis
What people are saying
The group's discussions revolve around the main conclusion that the pressure-limiting strategy did not improve patient outcomes, with posts referencing the trial's comparison between different ventilation strategies, like 'a driving pressure-guided strategy did not increase ventilator-free days.' The tone remains analytical and factual, reflecting an understanding of the study's neutral impact on clinical approaches.
Most discussions acknowledge that the study showed no significant benefit of the driving pressure-limiting strategy, reflecting a neutral stance overall.
The posts demonstrate moderate interest, with some sharing of findings and interpretations, but little exploration of deeper implications.
Discussions include citations of specific results, such as the comparison with ARDSNet and mentions of ventilator-free days, indicating thoughtful engagement.
The overall consensus suggests limited immediate impact on clinical practice, as the findings did not demonstrate a clear benefit, though some posts consider future research directions.
Abstract in brief
- This study evaluated whether a driving pressure-limiting ventilation strategy, based on PEEP titration according to lung compliance, could increase ventilator-free days in patients with moderate to severe ARDS from community-acquired pneumonia, but found no significant benefit.
- The trial was stopped early after enrolling 214 patients due to recruitment difficulties, with 198 patients analyzed, revealing no significant difference in ventilator-free days or mortality outcomes between the intervention and control groups.
- Overall, implementing a driving pressure-limiting approach did not improve outcomes compared to a standard low PEEP strategy in this patient population.]
Top posts
Most liked on X and Bluesky'In patients with moderate to severe ARDS secondary to community-acquired pneumonia, a driving pressure-limiting strategy did not increase the number of ventilator-free days compared with a standard low PEEP strategy' #critcaresky #emimcc pubmed.ncbi.nlm.nih.gov/39592365/
Compared with ARDSNet, a driving pressure-guided strategy did not increase ventilator-free days. https://t.co/0vaLxGV3vl
Effect of a driving pressure-limiting strategy for patients with acute respiratory distress syndrome secondary to community-acquired pneumonia: the STAMINA randomised clinical trial. See new work with contributions from @f_g_zampieri @UAlberta_FoMD https://t.co/CQJk44AyBk
RT @lessismoreicu: 市中肺炎に続発する中~重症ARDSにおいて、ΔP制限戦略(PEEPを最良の静的呼吸器系コンプライアンスで設定+ΔP≦14)は標準的な低PEEP戦略(ARDSnetの低PEEP表)と比べ、28日以内の非レスピ日数を増加させなかった、というRC…
RT @lessismoreicu: 市中肺炎に続発する中~重症ARDSにおいて、ΔP制限戦略(PEEPを最良の静的呼吸器系コンプライアンスで設定+ΔP≦14)は標準的な低PEEP戦略(ARDSnetの低PEEP表)と比べ、28日以内の非レスピ日数を増加させなかった、というRC…
All mentions
PEEP Titration Versus PEEP Table in ARDS Ventilation Strategies
This video explores the effectiveness of PEEP titration based on lung compliance versus using a PEEP table in ARDS management, highlighting recent trial findings that show no significant benefit of the driving…
Advances and Paradigms in Ventilatory Support for ARDS Patients
This episode features expert Ft Andr Nascimento discussing recent advances in ventilatory assistance and management of respiratory failure. He reviews strategies impacting clinical outcomes, different support…
3. Effect of a driving pressure-limiting strategy for patients with #ARDS secondary to #CAP -The Ventilator Strategy for Community Acquired Pneumonia (STAMINA) study was a multicenter, randomized trial comparing a driving-pressure limited strategy to a standard low PEEP https://t.co/iGWrjvdnBV
Effect of a driving pressure-limiting strategy for patients with acute respiratory distress syndrome secondary to community-acquired pneumonia: the STAMINA randomised clinical trial. See new work with contributions from @f_g_zampieri @UAlberta_FoMD https://t.co/CQJk44AyBk
RT @lessismoreicu: 市中肺炎に続発する中~重症ARDSにおいて、ΔP制限戦略(PEEPを最良の静的呼吸器系コンプライアンスで設定+ΔP≦14)は標準的な低PEEP戦略(ARDSnetの低PEEP表)と比べ、28日以内の非レスピ日数を増加させなかった、というRC…
RT @lessismoreicu: 市中肺炎に続発する中~重症ARDSにおいて、ΔP制限戦略(PEEPを最良の静的呼吸器系コンプライアンスで設定+ΔP≦14)は標準的な低PEEP戦略(ARDSnetの低PEEP表)と比べ、28日以内の非レスピ日数を増加させなかった、というRC…
RT @lessismoreicu: 市中肺炎に続発する中~重症ARDSにおいて、ΔP制限戦略(PEEPを最良の静的呼吸器系コンプライアンスで設定+ΔP≦14)は標準的な低PEEP戦略(ARDSnetの低PEEP表)と比べ、28日以内の非レスピ日数を増加させなかった、というRC…
RT @lessismoreicu: 市中肺炎に続発する中~重症ARDSにおいて、ΔP制限戦略(PEEPを最良の静的呼吸器系コンプライアンスで設定+ΔP≦14)は標準的な低PEEP戦略(ARDSnetの低PEEP表)と比べ、28日以内の非レスピ日数を増加させなかった、というRC…
RT @lessismoreicu: 市中肺炎に続発する中~重症ARDSにおいて、ΔP制限戦略(PEEPを最良の静的呼吸器系コンプライアンスで設定+ΔP≦14)は標準的な低PEEP戦略(ARDSnetの低PEEP表)と比べ、28日以内の非レスピ日数を増加させなかった、というRC…
RT @lessismoreicu: 市中肺炎に続発する中~重症ARDSにおいて、ΔP制限戦略(PEEPを最良の静的呼吸器系コンプライアンスで設定+ΔP≦14)は標準的な低PEEP戦略(ARDSnetの低PEEP表)と比べ、28日以内の非レスピ日数を増加させなかった、というRC…
RT @lessismoreicu: 市中肺炎に続発する中~重症ARDSにおいて、ΔP制限戦略(PEEPを最良の静的呼吸器系コンプライアンスで設定+ΔP≦14)は標準的な低PEEP戦略(ARDSnetの低PEEP表)と比べ、28日以内の非レスピ日数を増加させなかった、というRC…
RT @lessismoreicu: 市中肺炎に続発する中~重症ARDSにおいて、ΔP制限戦略(PEEPを最良の静的呼吸器系コンプライアンスで設定+ΔP≦14)は標準的な低PEEP戦略(ARDSnetの低PEEP表)と比べ、28日以内の非レスピ日数を増加させなかった、というRC…
市中肺炎に続発する中~重症ARDSにおいて、ΔP制限戦略(PEEPを最良の静的呼吸器系コンプライアンスで設定+ΔP≦14)は標準的な低PEEP戦略(ARDSnetの低PEEP表)と比べ、28日以内の非レスピ日数を増加させなかった、というRCT。 ΔPうんぬんよりPEEPはnetの表で悪くないのなってゆう https://t.co/wTYtLNdusb
'In patients with moderate to severe ARDS secondary to community-acquired pneumonia, a driving pressure-limiting strategy did not increase the number of ventilator-free days compared with a standard low PEEP strategy' #critcaresky #emimcc pubmed.ncbi.nlm.nih.gov/39592365/
Compared with ARDSNet, a driving pressure-guided strategy did not increase ventilator-free days. https://t.co/0vaLxGV3vl